63 related articles for article (PubMed ID: 2971807)
1. T-lymphocyte subsets and delayed type hypersensitivity as classification parameters for HIV infection among drug-addicts.
Lazzarin A; Negri C; Tambussi G; Saracco A; Galli M; Crocchiolo P; Irato L; Castagna A; Moroni M
J Clin Lab Immunol; 1988 Apr; 25(4):157-60. PubMed ID: 2971807
[TBL] [Abstract][Full Text] [Related]
2. The Walter Reed staging classification for HTLV-III/LAV infection.
Redfield RR; Wright DC; Tramont EC
N Engl J Med; 1986 Jan; 314(2):131-2. PubMed ID: 2934633
[TBL] [Abstract][Full Text] [Related]
3. Progressive cellular immune impairment leading to development of AIDS: two-year prospective study of HIV infection in drug addicts.
Fernandez-Cruz E; Fernandez AM; Gutierrez C; Garcia-Montes M; de la Morena MT; Rodriguez-Villanueva J; Longo N; Zabay JM
Clin Exp Immunol; 1988 May; 72(2):190-5. PubMed ID: 3261660
[TBL] [Abstract][Full Text] [Related]
4. [Difference in the behavior of T-lymphocyte populations in heroin and methadone addicts].
Brugo MA; Guffanti A; Guzzetti S; Pedretti D; Stringhetti M; Confalonieri F
Boll Ist Sieroter Milan; 1983; 62(6):517-23. PubMed ID: 6234006
[TBL] [Abstract][Full Text] [Related]
5. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
[TBL] [Abstract][Full Text] [Related]
6. [Study of immunologic parameters in parenteral drug addicts (PDA) with condylomata acuminata].
Marzo Lopez MC; Aguilar Ligorit E; Ramirez Bosca A; Montolio Doñate S; Soto Ferrando P; Castells Rodellas A
Med Cutan Ibero Lat Am; 1988; 16(3):187-91. PubMed ID: 2904516
[TBL] [Abstract][Full Text] [Related]
7. [Malignant melanoma and HIV infection].
Rasokat H; Steigleder GK; Bendick C; Müller S; Meller M
Z Hautkr; 1989 Jul; 64(7):581-2, 587. PubMed ID: 2528242
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of human T cell subsets defined by monoclonal antibodies. VI. Distinct and opposing immunoregulatory functions within the OKT8+ population.
Thomas Y; Rogozinski L; Rabbani L; Chess A; Goldstein G; Chess L
J Mol Cell Immunol; 1984; 1(2):103-13. PubMed ID: 6152892
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte chemotaxis in inflammation. X. Heterogeneity of chemotactic responsiveness in human T subsets towards lymphocyte chemotactic factors from delayed hypersensitivity reaction site.
Mibu Y; Shimokaway Y; Hayashi H
Immunology; 1985 Jul; 55(3):473-9. PubMed ID: 3874818
[TBL] [Abstract][Full Text] [Related]
10. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
Faure M; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
[TBL] [Abstract][Full Text] [Related]
11. Further dissection of the functional heterogeneity within the OKT4+ and OKT8+ human T cell subsets.
Thomas Y; Rogozinski L; Rothman P; Rabbani LE; Andrews S; Irigoyen OH; Chess L
J Clin Immunol; 1982 Jul; 2(3 Suppl):8S-14S. PubMed ID: 6215426
[TBL] [Abstract][Full Text] [Related]
12. [Clinical observation of the changes of serum helper T-lymphocytes (TH) cytokines in patients with HIV-infection and opportunistic infection].
Rao HP; Feng L; Li D; Bader A; Wu NP
Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jan; 41(1):42-5. PubMed ID: 17484210
[TBL] [Abstract][Full Text] [Related]
13. Depressed effector activity of OKT4+ and OKT8+ T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus.
Perl A; Gonzalez-Cabello R; Gergely P
J Clin Lab Immunol; 1984 Oct; 15(2):95-100. PubMed ID: 6240539
[TBL] [Abstract][Full Text] [Related]
14. Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the disease.
Lauria F; Foa R; Cavo M; Gobbi M; Raspadori D; Giubellino MC; Tazzari PL; Tura S
Clin Exp Immunol; 1984 Jun; 56(3):653-8. PubMed ID: 6235070
[TBL] [Abstract][Full Text] [Related]
15. Altered T-lymphocyte subsets in hospitalized intravenous drug abusers.
Layon J; Idris A; Warzynski M; Sherer R; Brauner D; Patch O; McCulley D; Orris P
Arch Intern Med; 1984 Jul; 144(7):1376-80. PubMed ID: 6610400
[TBL] [Abstract][Full Text] [Related]
16. Is T-cell activation an unfavourable sign in i.v.-drug addicts infected with HIV?
Fuchs DN; Hausen A; Hengster P; Reibnegger GJ; Unterweger B; Werner ER; Hinterhuber H; Dierich MP; Wachter H
Cancer Detect Prev; 1988; 12(1-6):277-82. PubMed ID: 3263196
[TBL] [Abstract][Full Text] [Related]
17. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
18. Clinical and immunological findings in HTLV-III infection.
Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A
Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
[TBL] [Abstract][Full Text] [Related]
19. T-lymphocyte subsets in primary and secondary glomerulonephritis.
Fornasieri A; Sinico R; Fiorini G; Goldaniga D; Colasanti G; Vendemia F; Gibelli A; D'Amico G
Proc Eur Dial Transplant Assoc; 1983; 19():635-41. PubMed ID: 6224213
[TBL] [Abstract][Full Text] [Related]
20. Immunologic abnormalities related to antigenaemia during HIV-1 infection.
De Paoli P; Battistin S; Crovatto M; Modolo ML; Carbone A; Tirelli U; Santini G
Clin Exp Immunol; 1988 Dec; 74(3):317-20. PubMed ID: 2976619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
